WHO Sets Up Panel To Review IPR Impact On Drugs
The commission, set up at the request of last year's World Health Assembly, will review existing research, development and innovation efforts directed at diseases that affect the poor.
Its report will consider how effectively intellectual property regimes and other incentive and funding mechanisms are stimulating research into new medicines against these diseases.
Governments, United Nations agencies, private-sector...
To view the full article, register now.